WATACHEM

Wata Chemicals Limited · Pharmaceuticals and Chemicals · Cat A

17/100

High risk

৳144.0

DSE Hexagon

Stands out for clean, organic trading, held back by little dividend.

Six lenses, each scored 0–100 from the analysis. Integrity is DSE-specific — it reads how organic the price action is (high = clean, low = concentrated-operator risk). Descriptive only, not a recommendation.

Risks & rewards

Risks (3)

⚠ Earnings trending down
⚠ Dividend sustainability at risk
⚠ Financial health deteriorating

Rewards (2)

✓ In an accumulation phase
✓ No signs of artificial price activity

Score breakdown

Price history & performance

52-week high৳162.1

52-week low৳101.9

From 52w high-11.2%

Beta0.98

7D +4.3%

1M +6.0%

3M +12.3%

6M +4.7%

1Y +39.8%

YTD +4.1%

Shareholder returns vs DSEX

WATACHEM+3.1%

DSEX+2.4%

WATACHEM outperformed the DSEX since Jul 8, 2026 — that's when we started tracking the index, so this window will get longer over time.

Volatility

Annualized volatility33.3%

Daily VaR (95%)-3.19%

Max drawdown (5y)-73.1%

Correlation to market0.49

Typical volatility for a DSE stock. Descriptive only — past volatility is not a forecast.

Technical read

RSI (14)65.7

MACDbullish

Bollingerabove upper band

Price cycle (Wyckoff)ACCUM

Health trenddeteriorating

Flow pressureaccumulation

Valuation

Fair value ()

Upside—

Dividend yield+0.70%

Fundamental verdictAT-RISK

Confidence—

Ownership

Institutional holding36.78%

Foreign holding0.0%

Free float26.81%

Sponsor, institutional, foreign and public holdings from the latest disclosed shareholding pattern. Descriptive only.

Share structure

Authorized capital৳150mn

Paid-up capital৳148.23mn

Face value৳10

Market lot1

Outstanding shares14,822,618

Last AGM24-12-2025

Fiscal year end30-Jun

Reserve & surplus (ex-OCI)৳725.8mn

Other comprehensive income৳-0.9mn

Financials

Recent P/E ratio

DateCurrent P/ETrailing P/E

Jul 14, 2026 127.41 157.23

Jul 13, 2026 124.14 153.19

Jul 12, 2026 124.66 153.83

Jul 9, 2026 122.24 150.85

Jul 8, 2026 120.43 148.62

Jul 7, 2026 120.34 148.51

Based on the latest un-audited financial statements. Descriptive only.

Dividend history

202510%

202412%

202315%

202220%

202130%

202035%

201930%

201810%

201710%

201610%

Earnings & NAV

YearEPSNAVDividend

2025 0.74 61.09 10%

2024 0.67 61.6 12%

2023 3.03 62.51 15%

2022 4.05 61.18 20%

Quarterly EPS — FY2026

Q10.67

Q20.13

Half-year0.8

Q30.07

Nine-month0.87

From disclosed annual reports and dividend declarations. Descriptive only, not a forecast.

Levels

Resistance

৳144.7

৳149.9

৳155

৳161.3

Support

৳143.5

৳137.1

৳132.9

৳126.8

Historical bounce zones

Nov 23, 2025: ৳105.6→৳125 +18%

Nov 25, 2025: ৳107.8→৳128.9 +20%

Dec 4, 2025: ৳114→৳137.2 +20%

Dec 18, 2025: ৳126→৳149.9 +19%

Feb 8, 2026: ৳129.5→৳150 +16%

Mar 8, 2026: ৳115→৳138 +20%

Apr 6, 2026: ৳121.6→৳146 +20%

Apr 20, 2026: ৳132→৳158 +20%

Sector peers

Other Pharmaceuticals and Chemicals names, ranked by our analysis score (DSE has no market-cap feed). Descriptive comparison only.

ScripScorePriceUpsideYield

IBNSINAThe IBN SINA Pharmaceutical Industry PLC 87 ৳326.5 +12.00% +2.00%MARICOMarico Bangladesh Limited 87 ৳2,732.4 +24.00% +2.20%SQURPHARMASquare Pharmaceuticals PLC. 85 ৳221.4 +120.00% +5.40%ACMELABThe ACME Laboratories Limited 79 ৳86.9 +138.00% +4.10%BXPHARMABeximco Pharmaceuticals PLC. 78 ৳153.2 +54.00% +2.60%RENATARenata PLC 64 ৳464.3 -25.00% +1.20%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 40% vs 40% market avg Typical move: -5.9% / -1.3% / 5.2%

30-day 41% vs 42% market avg Typical move: -10% / -2.3% / 8.3%

Signals: RSI>70 overbought|Above upper Bollinger|Stochastic>80|Tweezer Top

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readAVOID (no entry)

Reference stopif held: EXIT now / close<136.7

Reference target—

Timing noteexit / stay out

Organic (score 101) — clean price history; historically holds its uptrend above the 50-day average. Real earnings. [fundamentals AT-RISK (dividend cut risk), payout 135.0%, yield 0.7%]